Evelyn Mei Huang

Array ( [id] => 4305455 [patent_doc_number] => 06326379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Fused pyridine inhibitors of cGMP phosphodiesterase' [patent_app_type] => 1 [patent_app_number] => 9/393833 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12530 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 634 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326379.pdf [firstpage_image] =>[orig_patent_app_number] => 393833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4160137 [patent_doc_number] => 06114533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => '2,4-pentadienoic acid derivatives having retinoid-like biological activity' [patent_app_type] => 1 [patent_app_number] => 9/390825 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15672 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 325 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114533.pdf [firstpage_image] =>[orig_patent_app_number] => 390825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252316 [patent_doc_number] => 06207677 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Piperidine derivatives having anxiolytic effect' [patent_app_type] => 1 [patent_app_number] => 9/391290 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18722 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 470 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207677.pdf [firstpage_image] =>[orig_patent_app_number] => 391290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237731 [patent_doc_number] => 06143759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Tetrazoles' [patent_app_type] => 1 [patent_app_number] => 9/367852 [patent_app_country] => US [patent_app_date] => 1999-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8479 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143759.pdf [firstpage_image] =>[orig_patent_app_number] => 367852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602762 [patent_doc_number] => 06432941 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Vanadium compounds for treating cancer' [patent_app_type] => B1 [patent_app_number] => 09/378531 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 24445 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432941.pdf [firstpage_image] =>[orig_patent_app_number] => 09378531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356110 [patent_doc_number] => 06218401 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase' [patent_app_type] => 1 [patent_app_number] => 9/374392 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13968 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218401.pdf [firstpage_image] =>[orig_patent_app_number] => 374392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288547 [patent_doc_number] => 06211192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Alkynyl-substituted camptothecins and process for their preparation' [patent_app_type] => 1 [patent_app_number] => 9/355952 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6847 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 368 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211192.pdf [firstpage_image] =>[orig_patent_app_number] => 355952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371181 [patent_doc_number] => 06288081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith' [patent_app_type] => 1 [patent_app_number] => 9/319848 [patent_app_country] => US [patent_app_date] => 1999-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16342 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288081.pdf [firstpage_image] =>[orig_patent_app_number] => 319848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4089878 [patent_doc_number] => 06133282 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Certain pyrrolopyridine derivatives; novel CRF1 specific ligands' [patent_app_type] => 1 [patent_app_number] => 9/368541 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7151 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133282.pdf [firstpage_image] =>[orig_patent_app_number] => 368541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4412027 [patent_doc_number] => 06265575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Antithrombotic diamines' [patent_app_type] => 1 [patent_app_number] => 9/369416 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136998 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265575.pdf [firstpage_image] =>[orig_patent_app_number] => 369416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4277445 [patent_doc_number] => 06281220 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Deazapurine derivatives; a new class of CRF1 specific ligands' [patent_app_type] => 1 [patent_app_number] => 9/368543 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5976 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 376 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281220.pdf [firstpage_image] =>[orig_patent_app_number] => 368543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407714 [patent_doc_number] => 06172067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => '2-substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists' [patent_app_type] => 1 [patent_app_number] => 9/369208 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39901 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 421 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172067.pdf [firstpage_image] =>[orig_patent_app_number] => 369208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109520 [patent_doc_number] => 06057335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Pyrazole derivatives' [patent_app_type] => 1 [patent_app_number] => 9/319260 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12334 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057335.pdf [firstpage_image] =>[orig_patent_app_number] => 319260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190586 [patent_doc_number] => 06153624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders' [patent_app_type] => 1 [patent_app_number] => 9/362932 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5159 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153624.pdf [firstpage_image] =>[orig_patent_app_number] => 362932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788664 [patent_doc_number] => 20020161005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR' [patent_app_type] => new [patent_app_number] => 09/362796 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 11824 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161005.pdf [firstpage_image] =>[orig_patent_app_number] => 09362796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381565 [patent_doc_number] => 20020119973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREFOR' [patent_app_type] => new [patent_app_number] => 09/362837 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 42539 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119973.pdf [firstpage_image] =>[orig_patent_app_number] => 09362837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099387 [patent_doc_number] => 06048869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Tricyclic compounds' [patent_app_type] => 1 [patent_app_number] => 9/360266 [patent_app_country] => US [patent_app_date] => 1999-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25098 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048869.pdf [firstpage_image] =>[orig_patent_app_number] => 360266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410542 [patent_doc_number] => 06228868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Oxazoline antiproliferative agents' [patent_app_type] => 1 [patent_app_number] => 9/360463 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29596 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 735 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228868.pdf [firstpage_image] =>[orig_patent_app_number] => 360463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4350347 [patent_doc_number] => 06214838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Thienodipyridine derivatives, production and use thereof' [patent_app_type] => 1 [patent_app_number] => 9/355218 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14727 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214838.pdf [firstpage_image] =>[orig_patent_app_number] => 355218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291353 [patent_doc_number] => 06211372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Pharmaceutical compositions and methods for use' [patent_app_type] => 1 [patent_app_number] => 9/358590 [patent_app_country] => US [patent_app_date] => 1999-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11869 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211372.pdf [firstpage_image] =>[orig_patent_app_number] => 358590 [rel_patent_id] =>[rel_patent_doc_number] =>)